LpxC inhibitors (Genesoft)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameLpxC inhibitors (Genesoft)
Drug Alias NameLpxC inhibitors (British Biotech)N-acetylglucosamine deacetylase inhibitors (Genesoft)BB-78484BB-78485
ClassificationSmall molecules
Mechanisms of ActionUDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitors
TargetsUDP-3-O-acyl-N-acetylglucosamine deacetylase
Therapy Area/IndicationsUrinary Tract InfectionsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVernalis Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenesoft IncVernalis Plc
Active IndicationsN/A
Inactive IndicationsUrinary Tract InfectionsGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A